Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac N.V (CVAC) Gross Margin: 2019-2025

Historic Gross Margin for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -77.67%.

  • CureVac N.V's Gross Margin rose 10442.00% to -77.67% in Q2 2025 from the same period last year, while for Jun 2025 it was 94.81%, marking a year-over-year increase of 23796.00%. This contributed to the annual value of 80.23% for FY2024, which is 21157.00% up from last year.
  • Per CureVac N.V's latest filing, its Gross Margin stood at -77.67% for Q2 2025, which was down 3,953.33% from 2.02% recorded in Q1 2025.
  • CureVac N.V's Gross Margin's 5-year high stood at 95.56% during Q3 2024, with a 5-year trough of -583.77% in Q4 2022.
  • In the last 3 years, CureVac N.V's Gross Margin had a median value of -107.41% in 2025 and averaged -92.44%.
  • In the last 5 years, CureVac N.V's Gross Margin crashed by 51,382bps in 2022 and then soared by 44,662bps in 2023.
  • CureVac N.V's Gross Margin (Quarterly) stood at -69.95% in 2021, then tumbled by 51,382bps to -583.77% in 2022, then spiked by 44,662bps to -137.15% in 2023, then soared by 22,691bps to 89.76% in 2024, then soared by 10,442bps to -77.67% in 2025.
  • Its last three reported values are -77.67% in Q2 2025, 2.02% for Q1 2025, and 89.76% during Q4 2024.